mutations given The reality that, as defined below, CLL therapy is based on the presence or absence of such mutations. The current consensus is the fact, aside from clonal mutations, subclonal mutations that has a variant allelic frequency ranging from 5 to 10% (and as a consequence beneath the brink of detection by conventional molecular strategie